02.04.2015 • News

Sale of DSM Synres Completed

Dutch life sciences and materials sciences company DSM has finalised the sale of DSM Synres to private equity firm Standard Investment. Financial details of the sale, which was announced on December 17 last year, were not disclosed.

DSM Synres produces solvent-borne alkyd and acrylic coating resins at its site in Hoek van Holland for the global coatings, adhesives and graphic arts markets. It has sales of around €50 million and about 80 employees.

Standard Investment, based in Amsterdam, focuses on small and medium-sized enterprises in the Netherlands and Belgium. It has acquired 18 companies since its establishment in 2004.

Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Top-Feature

most read